FDA Develops List of Bulk Drug Substances for Clinical Need Under Section 503B of the FD&C Act

Summary

The FDA is creating a list of bulk drug substances that have a clinical need, allowing outsourcing facilities to compound certain drugs with exemptions from the FD&C Act, with two substances proposed for inclusion and three not included, and additional substances under consideration